CES 2018 Features Dynafocals Smart Reading Glasses by PH Technical Labs

January 12, 2018: By Joan McKenna
    Dynafocals smart glassesDynafocals smart glasses

Ophthalmic products at CES 2018 included the Dynafocals smart reading glasses by PH Technical Labs of Plano, Texas. The conference was held Jan. 7-12 in Las Vegas.

The glasses dynamically change focus for the user based on what is viewed using a distance sensing chip and standard progressive lens. The glasses allow the user to see distant objects, computer screens, or near print without changing head positions, PH Technical says.

The company describes the glasses as providing a complete solution for all focus vision needs in a sleek, comfortable, and affordable pair of glasses.

PH Technical says it plans to launch the glasses in the middle of 2018.

The company was named a CES 2018 Innovation Awards Honoree in November.

The CES 2018 conference draws more than 180 thousand attendees and 4 thousand exhibitors.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

US Health Secretary Alex Azar Takes Aim at Rebates in US Senate Hearing

Beyeonics Surgical Raises $11.5 Million in Initial Funding Round

MeiraGTx Raises $75 Million in Initial Public Offering

GenSight to Pursue Approval for LHON Gene Therapy Candidate, Despite Phase III Setback

Optovue Receives FDA Clearance for AngioAnalytics, First OCT Angiography Metrics

Nexy Robotic Retinal Imaging System Receives FDA Clearance

Ocutrx Receives US Patent for Oculenz AR Glasses for Macular Degeneration

Allergan’s Bimatoprost SR Demonstrates Noninferiority to Timolol in Phase III Glaucoma Study

KKR to acquire Envision Healthcare, Including Amsurg ASC Business

Ophthalmologist Carmen Puliafito, MD, Seeks to Regain Medical License

Avedro Gains J Code for Photrexa Formulations in Preliminary CMS Decision

EyeGate Seeks to Study Ocular Bandage Gel in Punctate Epitheliopathy

Nicox, Ironwood to Collaborate on Novel Ophthalmic Treatments

US FDA Approves MDGH’s Moxidectin for Treatment of River Blindness

Bausch + Lomb Enrolls First Patient in Trial for enVista MX60EF Trifocal IOL

Cincinnati Eye Institute Partners with Private Equity Firm to Pursue National Expansion

Ophthotech Enters Gene Therapy Deals with University of Florida, University of Pennsylvania

Teva’s Launches Generic Version of Restasis in Canada

Clearside’s Phase II Trial for DME Candidate Meets Primary Endpoint

Orasis Raises $13 Million in Series B Financing

Coming soon

2018 Optical Coherence Tomography Report: A Global Market Analysis for 2017 to 2023